JP2021500070A5 - - Google Patents

Download PDF

Info

Publication number
JP2021500070A5
JP2021500070A5 JP2020542536A JP2020542536A JP2021500070A5 JP 2021500070 A5 JP2021500070 A5 JP 2021500070A5 JP 2020542536 A JP2020542536 A JP 2020542536A JP 2020542536 A JP2020542536 A JP 2020542536A JP 2021500070 A5 JP2021500070 A5 JP 2021500070A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
capsid protein
protein corresponding
aav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020542536A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500070A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/056271 external-priority patent/WO2019079437A1/en
Publication of JP2021500070A publication Critical patent/JP2021500070A/ja
Publication of JP2021500070A5 publication Critical patent/JP2021500070A5/ja
Pending legal-status Critical Current

Links

JP2020542536A 2017-10-18 2018-10-17 Hbb遺伝子機能を回復させるためのアデノ随伴ウイルス組成物およびその使用方法 Pending JP2021500070A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762574163P 2017-10-18 2017-10-18
US62/574,163 2017-10-18
US201862621102P 2018-01-24 2018-01-24
US62/621,102 2018-01-24
PCT/US2018/056271 WO2019079437A1 (en) 2017-10-18 2018-10-17 ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING THE FUNCTION OF THE HBB GENE AND METHODS OF USE

Publications (2)

Publication Number Publication Date
JP2021500070A JP2021500070A (ja) 2021-01-07
JP2021500070A5 true JP2021500070A5 (https=) 2021-12-02

Family

ID=64332161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020542536A Pending JP2021500070A (ja) 2017-10-18 2018-10-17 Hbb遺伝子機能を回復させるためのアデノ随伴ウイルス組成物およびその使用方法

Country Status (12)

Country Link
US (1) US12201657B2 (https=)
EP (1) EP3697450A1 (https=)
JP (1) JP2021500070A (https=)
KR (1) KR20200095462A (https=)
CN (1) CN111447954A (https=)
AU (1) AU2018352855B2 (https=)
BR (1) BR112020007765A2 (https=)
CA (1) CA3079437A1 (https=)
IL (1) IL273877A (https=)
MX (1) MX2020004092A (https=)
SG (1) SG11202002737PA (https=)
WO (1) WO2019079437A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109536494A (zh) * 2017-10-31 2019-03-29 广东赤萌医疗科技有限公司 一种用于修复HBB1基因点突变的gRNA、基因编辑系统、表达载体和基因编辑试剂盒
EP4085143B1 (en) * 2019-12-31 2025-08-13 Swanbio Therapeutics Limited Improved aav-abcd1 constructs and use for treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn)
CN111363756B (zh) * 2020-04-02 2023-01-17 中国医学科学院血液病医院(中国医学科学院血液学研究所) 一种珠蛋白基因双表达慢病毒载体及其应用
WO2021207077A1 (en) * 2020-04-06 2021-10-14 Homology Medicines, Inc. Adeno-associated virus compositions for ids gene transfer and methods of use thereof
WO2022221319A2 (en) * 2021-04-12 2022-10-20 Graphite Bio, Inc. Methods and compositions for production of genetically modified primary cells
US20250127812A1 (en) * 2021-08-10 2025-04-24 GentiBio. Inc. Compositions and methods for engineering stable tregs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449759A (en) * 1987-05-16 1995-09-12 Somatogen, Inc. Hemoglobins with intersubunit desulfide bonds
US5252479A (en) * 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
DE69727492T2 (de) * 1996-12-05 2004-12-16 Crucell Holland B.V. Genetische modifikation der hämatopoietischen repopulation von stammzellen in primaten
US9725485B2 (en) * 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
CN101348786B (zh) * 2007-07-20 2011-05-11 谭孟群 一种人β珠蛋白基因及其重组腺相关病毒载体
WO2009013559A1 (en) 2007-07-23 2009-01-29 Cellectis Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
US8628966B2 (en) * 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
US11242525B2 (en) * 2014-03-26 2022-02-08 Editas Medicine, Inc. CRISPR/CAS-related methods and compositions for treating sickle cell disease
CA2960209C (en) 2014-09-04 2023-08-29 Memorial Sloan-Kettering Cancer Center Globin gene therapy for treating hemoglobinopathies
BR112017005892A2 (pt) * 2014-09-24 2017-12-12 Hope City variantes de vetor de vírus adeno-associado para edição de genoma de alta eficácia e métodos da mesma
US20180135074A1 (en) * 2015-02-19 2018-05-17 University Of Florida Research Foundation, Incorporated Recombinant aav vectors for gene therapy of human hematopoietic disorders
US11136597B2 (en) * 2016-02-16 2021-10-05 Yale University Compositions for enhancing targeted gene editing and methods of use thereof

Similar Documents

Publication Publication Date Title
US11091777B2 (en) Synthetic combinatorial AAV capsid library for targeted gene therapy
JP2021500070A5 (https=)
AU2014324717A1 (en) Synthetic combinatorial AAV capsid library for targeted gene therapy
JP2020054367A (ja) 改変g6pcをコードするアデノ随伴ウイルスベクターおよびその使用
EP3133923B1 (en) Aav-based gene therapy for multiple sclerosis
EP4601612A2 (en) Nucleic acid regulatory elements for gene expression in the muscle and methods of use
JP2021512871A5 (https=)
CN111718420A (zh) 一种用于基因治疗的融合蛋白及其应用
WO2023202469A1 (zh) 一种用于遗传性凝血因子缺乏病治疗的核酸构建体及其用途
WO2022226183A2 (en) Optimized ap4m1 polynucleotides and expression cassettes and their use
CN115605266A (zh) Dysferlin双载体的基因疗法
US20190276856A1 (en) Adeno-associated virus compositions for restoring f8 gene function and methods of use thereof
CN117003833A (zh) 肝脏特异性的腺相关病毒血清型及应用
JPWO2019152843A5 (https=)
KR102874560B1 (ko) 아데노연관바이러스 변이체
US12480098B1 (en) Adeno-associated virus variant
WO2024094009A1 (zh) 用于目的基因的表达盒及其应用
WO2026032020A1 (zh) Aav介导的rpgr x连锁视网膜变性的基因编辑治疗方法
CA2930549C (en) Synthetic combinatorial aav capsid library for targeted gene therapy
KR20260057323A (ko) 아데노연관바이러스 변이체
HK40041411A (en) Aav-based gene therapy for multiple sclerosis